Insmed Incorporated Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 306.0M | 263.8M | 142.3M | 107.4M | 92.8M | 104.4M | 93.4M | 90.3M |
| Cost of Goods Sold | 49.5M | 44.2M | 29.4M | 28.1M | 21.3M | 26.2M | 21.2M | 21.0M |
| Gross Profit | 256.5M | 219.6M | 113.0M | 79.3M | 71.5M | 78.3M | 72.3M | 69.4M |
| R&D Expenses | 209.5M | 254.9M | 186.4M | 177.2M | 152.6M | 179.7M | 150.8M | 146.7M |
| Operating Expenses | 456.7M | 469.3M | 479.0M | 392.2M | 319.7M | 308.7M | 285.7M | 358.3M |
| Operating Income | -200.3M | -249.7M | -366.0M | -312.9M | -248.1M | -230.4M | -213.4M | -288.9M |
| Other Income / Gains | 38.2M | -77.2M | -2.7M | -7.6M | -7.5M | -3.9M | -6.1M | -10.9M |
| Net Income | -163.6M | -328.5M | -370.0M | -321.7M | -256.6M | -235.5M | -220.5M | -300.6M |
| EPS (Diluted) | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.838 | 0.832 | 0.794 | 0.739 | 0.771 | 0.75 | 0.773 | 0.768 |
| General And Administrative Expenses | 0 | 212.5M | 186.4M | 154.8M | 147.5M | 142.5M | 118.9M | 106.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 247.3M | 212.5M | 186.4M | 154.8M | 147.5M | 142.5M | 118.9M | 106.6M |
| Other Expenses | 0 | 1.9M | 106.2M | 60.3M | 19.6M | -13.5M | 15.9M | 105.0M |
| Cost And Expenses | 506.2M | 513.6M | 508.3M | 420.3M | 341.0M | 334.9M | 306.9M | 379.2M |
| Interest Income | 12.0M | 15.2M | 18.3M | 13.2M | 13.9M | 17.3M | 17.0M | 10.3M |
| Interest Expense | 20.1M | 20.6M | 20.4M | 21.2M | 21.6M | 21.6M | 21.1M | 21.3M |
| Depreciation And Amortization | 5.7M | 5.6M | 4.0M | 3.7M | 3.1M | 2.7M | 2.7M | 2.7M |
| Ebitda | -136.3M | -302.1M | -345.7M | -297.1M | -232.8M | -211.7M | -196.5M | -276.9M |
| Ebitdaratio | -0.446 | -1.145 | -2.428 | -2.766 | -2.508 | -2.027 | -2.103 | -3.065 |
| Operating Income Ratio | -0.655 | -0.946 | -2.571 | -2.913 | -2.673 | -2.206 | -2.284 | -3.198 |
| Income Before Tax | -162.1M | -326.9M | -368.7M | -320.4M | -255.7M | -234.3M | -219.5M | -299.8M |
| Income Before Tax Ratio | -0.53 | -1.239 | -2.59 | -2.983 | -2.754 | -2.243 | -2.35 | -3.318 |
| Income Tax Expense | 1.5M | 1.6M | 1.3M | 1.2M | 912K | 1.3M | 1.0M | 838K |
| Net Income Ratio | -0.535 | -1.245 | -2.60 | -2.995 | -2.764 | -2.255 | -2.36 | -3.328 |
| Epsdiluted | -0.76 | -1.54 | -1.75 | -1.70 | -1.42 | -1.32 | -1.27 | -1.94 |
| Weighted Average Shs Out | 215.5M | 213.6M | 211.8M | 189.3M | 180.9M | 179.0M | 173.7M | 154.7M |
| Weighted Average Shs Out Dil | 215.5M | 213.6M | 211.4M | 189.3M | 180.9M | 179.0M | 173.7M | 154.7M |